Click to read the publication:
TOWARDS A SMOKE-FREE ASEAN AND BEYOND:
 A Decade of Advancing A Genuine Smoke-Free Future

Links to PDF documents:

1.) Minimum Standard Operating Procedure (SOP)
for the Implementation of a Smoke-Free Environment in the Tourism Sector

2.) Implementing Guidelines for Smoke-free Tourism City

Click to read the publication:
Smoke-free Index Myanmar

EDMONTON, TORONTO and BOSTON, Monday, December 26, 2022 /CNW/ - Civil society organizations are hailing the expulsion of tobacco giant Philip Morris from Canada's major government-backed COVID-19 vaccine collaboration, Medicago Inc. Majority owner Mitsubishi Tanabe Pharma has removed Philip Morris as a secondary investor. The news follows the rejection of Medicago's Covifenz vaccine by the World Health Organization (WHO) in March due to the corporation's tobacco industry ties.

"Tobacco corporations, vaccines and governments don't mix well and we applaud the expulsion of Philip Morris from the Medicago collaboration," said Les Hagen, executive director of ASH Canada. "Tobacco industry products are responsible for over eight million deaths annually worldwide and tobacco corporations are desperately trying to whitewash their terrible public image by investing in the health sector. However, the control of one pandemic should not come at the expense of another. We are relieved that Canadian governments have washed their hands of this unethical and embarrassing collaboration with a tobacco giant." READ MORE